These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25589068)

  • 21. Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome.
    Chakrabarti LA; Boucherie C; Bugault F; Cumont MC; Roussillon C; Breton G; Patey O; Chêne G; Richert L; Lortholary O;
    AIDS; 2014 Jul; 28(11):1593-602. PubMed ID: 24865974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection.
    Conradie F; Foulkes AS; Ive P; Yin X; Roussos K; Glencross DK; Lawrie D; Stevens W; Montaner LJ; Sanne I; Azzoni L
    J Acquir Immune Defic Syndr; 2011 Nov; 58(3):309-18. PubMed ID: 21826013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invariant Natural Killer T-cell Dynamics in Human Immunodeficiency Virus-associated Tuberculosis.
    Walker NF; Opondo C; Meintjes G; Jhilmeet N; Friedland JS; Elkington PT; Wilkinson RJ; Wilkinson KA
    Clin Infect Dis; 2020 Apr; 70(9):1865-1874. PubMed ID: 31190065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skewing of the CD4(+) T-cell pool toward monofunctional antigen-specific responses in patients with immune reconstitution inflammatory syndrome in The Gambia.
    Wilson H; de Jong BC; Peterson K; Jaye A; Kampmann B; Ota MO; Sutherland JS
    Clin Infect Dis; 2013 Aug; 57(4):594-603. PubMed ID: 23645847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand.
    Tieu HV; Ananworanich J; Avihingsanon A; Apateerapong W; Sirivichayakul S; Siangphoe U; Klongugkara S; Boonchokchai B; Hammer SM; Manosuthi W
    AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1083-9. PubMed ID: 19886838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.
    Worodria W; Menten J; Massinga-Loembe M; Mazakpwe D; Bagenda D; Koole O; Mayanja-Kizza H; Kestens L; Mugerwa R; Reiss P; Colebunders R;
    Antivir Ther; 2012; 17(5):841-8. PubMed ID: 22543224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis.
    Pean P; Nerrienet E; Madec Y; Borand L; Laureillard D; Fernandez M; Marcy O; Sarin C; Phon K; Taylor S; Pancino G; Barré-Sinoussi F; Scott-Algara D;
    Blood; 2012 Apr; 119(14):3315-20. PubMed ID: 22343919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis.
    Bell LC; Breen R; Miller RF; Noursadeghi M; Lipman M
    Int J Infect Dis; 2015 Mar; 32():39-45. PubMed ID: 25809754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome.
    Lai RP; Meintjes G; Wilkinson RJ
    Semin Immunopathol; 2016 Mar; 38(2):185-98. PubMed ID: 26423994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classical complement and inflammasome activation converge in CD14highCD16- monocytes in HIV associated TB-immune reconstitution inflammatory syndrome.
    Lage SL; Wong CS; Amaral EP; Sturdevant D; Hsu DC; Rupert A; Wilson EMP; Qasba SS; Naqvi NS; Laidlaw E; Lisco A; Manion M; Sereti I
    PLoS Pathog; 2021 Mar; 17(3):e1009435. PubMed ID: 33788899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
    Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX;
    AIDS; 2013 Oct; 27(16):2577-86. PubMed ID: 24096631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [IRIS: a paradoxical inflammatory reaction in patients treated simultaneously for tuberculosis and HIV].
    Chakrabarti LA; Lortholary O
    Med Sci (Paris); 2015 Jan; 31(1):53-9. PubMed ID: 25658731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
    Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TB-IRIS: Proteomic analysis of in vitro PBMC responses to Mycobacterium tuberculosis and response modulation by dexamethasone.
    Bell L; Peyper JM; Garnett S; Tadokera R; Wilkinson R; Meintjes G; Blackburn JM
    Exp Mol Pathol; 2017 Apr; 102(2):237-246. PubMed ID: 28209523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and its influence on tuberculosis treatment outcomes in persons living with HIV.
    Narendran G; Jyotheeswaran K; Senguttuvan T; Vinhaes CL; Santhanakrishnan RK; Manoharan T; Selvaraj A; Chandrasekaran P; Menon PA; Bhavani KP; Reddy D; Narayanan R; Subramanyam B; Sathyavelu S; Krishnaraja R; Kalirajan P; Angamuthu D; Susaimuthu SM; Ganesan RRK; Tripathy SP; Swaminathan S; Andrade BB
    Int J Infect Dis; 2020 Sep; 98():261-267. PubMed ID: 32623087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome.
    Conesa-Botella A; Loembé MM; Manabe YC; Worodria W; Mazakpwe D; Luzinda K; Mayanja-Kizza H; Miri M; Mbabazi O; Koole O; Kestens L; Colebunders R;
    J Acquir Immune Defic Syndr; 2011 Dec; 58(5):463-8. PubMed ID: 21963941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of elevated pre-ART elastase-ANCA levels in patients developing TB-IRIS.
    Goovaerts O; Massinga-Loembé M; Ondoa P; Ceulemans A; Worodria W; Mayanja-Kizza H; Colebunders R; Kestens L;
    PLoS One; 2020; 15(12):e0244800. PubMed ID: 33382831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.
    Breton G; Bourgarit A; Pavy S; Bonnet D; Martinez V; Duval X; Longuet P; Abgrall S; Simon A; Leport C;
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1365-70. PubMed ID: 23107635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and risk factors of paradoxical tuberculosis associated immune reconstitution inflammatory syndrome among HIV-infected patients in Beijing, China.
    Xue M; Xie R; Pang Y; Yan S; Du Y; Guan C; Chen B
    BMC Infect Dis; 2020 Jul; 20(1):554. PubMed ID: 32736608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome.
    Conesa-Botella A; Meintjes G; Coussens AK; van der Plas H; Goliath R; Schutz C; Moreno-Reyes R; Mehta M; Martineau AR; Wilkinson RJ; Colebunders R; Wilkinson KA
    Clin Infect Dis; 2012 Oct; 55(7):1004-11. PubMed ID: 22715179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.